Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD1 | Q15139 | 5/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.37 |
| ▸ | ATR | Q13535 | 6/20 | 0.35 |
| ▸ | ATM | Q13315 | 3/20 | 0.35 |
| ▸ | PRKDC | P78527 | 2/20 | 0.35 |
| ▸ | RAF1 | P04049 | 3/20 | 0.35 |
| ▸ | BRAF | P15056 | 2/20 | 0.35 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | KIT | P10721 | 1/20 | 0.34 |
| ▸ | SERPINA2 | P20848 | 1/20 | 0.34 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.34 |
| ▸ | FLT4 | P35916 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14865613 | 0.89 | PRKD1 (0.43) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14866769 | 0.88 | ATR (0.49) | ATRATMPRKDCJAK2ABL1 | |
| SCHEMBL14865751 | 0.87 | RAF1 (0.36) | ATRRAF1BRAFEGLN2 | |
| SCHEMBL14865627 | 0.87 | ATR (0.45) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14865770 | 0.86 | S1PR1 (0.39) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14865636 | 0.85 | PRKD1 (0.46) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14865771 | 0.85 | PRKD1 (0.34) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14865823 | 0.85 | PRKD1 (0.48) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14865735 | 0.85 | PRKD1 (0.48) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL14865695 | 0.84 | PRKD1 (0.52) | PRKD1CYP3A4CYP2C19CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130095193-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130095193-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, CHEK1, CHEK2 | PRKD1 89/4885CYP3A4 4509/4885CYP2C19 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.